Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

BACKGROUND: Despite introduction of effective chemotherapy protocols, it has remained uncertain, if patients with colorectal cancer (CRC) liver metastases should receive adjuvant therapy. Clinical or molecular predictors may help to select patients at high risk for disease recurrence and death who o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahbari, Nuh N, Reissfelder, Christoph, Schulze-Bergkamen, Henning, Jäger, Dirk, Büchler, Markus W, Weitz, Jürgen, Koch, Moritz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008001/
https://www.ncbi.nlm.nih.gov/pubmed/24612620
http://dx.doi.org/10.1186/1471-2407-14-174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008001/
https://www.ncbi.nlm.nih.gov/pubmed/24612620
http://dx.doi.org/10.1186/1471-2407-14-174

Ejemplares similares